https://www.labiotech.eu/trends-news/biocartis-starts-european-commercialization-liver-cancer-test/
0
0
10/10/22 at 10:29am
Organization
Labiotech.eu
Author
Jim Cornall
30 words
0
Comments
Biocartis Group NV has started the commercialization in Europe of the HepatoPredict test as a CE-IVD marked manual kit.
You are the first to view
Create an account
or login to join the discussion